My watch list
my.bionity.com  
Login  

Disease mongering



Disease mongering is a term used to describe a perceived attempt by pharmaceutical companies to promote public awareness of relatively minor conditions or diseases with the aim of increasing sales of medication.[1] Examples include male-type baldness and certain social phobias.[1] In discussions specifically about the validity of psychiatry, the term is frequently also used by proponents of the antipsychiatry movement[2] and Scientology[3] based critics to discredit psychiatry, neurobiological disorders, and the medications used for treatment. Examples include ADHD[4] and bipolar disorder[5].

Additional recommended knowledge

Proponents of this practice argue that the pharmaceutical industry is only providing the public with information about its options and that actual prescription is a matter to be discussed between patient and doctor. Opponents, however, claim that this approach leads to the unnecessary prescription of drugs, that its motivation is only to profit the drug companies, and that it may actually harm instead of help patients.[1]

A 2006 Newcastle, New South Wales conference, reported in PLoS Medicine, explored the phenomenon further[6] Journalist Moynihan satirised it in a BMJ "news" item that appeared in its April Fool's Day edition 2006, titled "Scientists find new disease: motivational deficiency disorder".[7]

See also

References

  1. ^ a b c Moynihan R, Heath I, Henry D (2002). "Selling sickness: the pharmaceutical industry and disease mongering". BMJ 324 (7342): 886-91. PMID 11950740.
  2. ^ Fred Baughman (2000-09-25). The Rise and Fall of ADD/ADHD. ICSPP. Retrieved on 2007-06-03.
  3. ^ Stephen Barlas and Psychiatric Times staff (2006-04-16). Psychiatric Profession Current Target of Citizens Commission on Human Rights. CCHR. Retrieved on 2007-06-03.
  4. ^ Kage B (2006-09-22). Celebrity-endorsed ADHD "educational ad" spreads Big Pharma disease mongering across internet. NewsTarget.com. Retrieved on 2007-06-12.
  5. ^ Healy D (2006). "The latest mania: selling bipolar disorder". PLoS Med. 3 (4): e185. doi:10.1371/journal.pmed.0030185. PMID 16597178.
  6. ^ Moynihan R, Henry D (eds).. A Collection of Articles on Disease Mongering.. PLoS medicine, 2006.. Retrieved on 2007-06-12.
  7. ^ Moynihan R (2006). "Scientists find new disease: motivational deficiency disorder.". BMJ 332: p. 745.

Further reading

  • Payer, Lynn (1992). Disease-Mongers. New York: John Wiley. ISBN 0-47100-737-4. 
  • Moynihan, Ray; Alan Cassels (2005). Selling sickness: How the world's biggest pharmaceutical companies are turning us all into patients. New York: Nation Books. ISBN 1-56025-697-4. 
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Disease_mongering". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE